Shuji Ozaki

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 348 citations · Full text

Hematological Malignancy, Proteasome Inhibitors, Relapsed Myeloma +10

Myeloma cells suppress bone formation by secreting a soluble Wnt inhibitor, sFRP-2

Takashi Oshima, Masahiro Abe, Jin Asano et al. · Blood · 2005 · 343 citations · Full text

Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment

Koichiro Hayashi, Michihiro Nakamura, Wataru Sakamoto et al. · Theranostics · 2013 · 328 citations · Full text

Nanoparticles, Engineering, Magnetic Resonance +20

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

Masahiro Abe, Kenji Hiura, Javier Wilde et al. · Blood · 2004 · 314 citations

Role for macrophage inflammatory protein (MIP)-1α and MIP-1β in the development of osteolytic lesions in multiple myeloma

Masahiro Abe, Kenji Hiura, Javier Wilde et al. · Blood · 2002 · 285 citations · Full text